Insys Agrees to $225 Million, 5-Year Settlement of US Opioid Sales C...

06/06/19

Insys Agrees to $225 Million, 5-Year Settlement of US Opioid Sales Claims  Claims Journal

Insys Therapeutics Inc., grappling with the prospect of bankruptcy after its founder was convicted on racketeering charges, agreed to pay $225 million to.

[more]